Yüklüyor......

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drugs R D
Asıl Yazarlar: Auffret, Manon, Drapier, Sophie, Vérin, Marc
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/
https://ncbi.nlm.nih.gov/pubmed/29546602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!